Trademarkia Logo

Canada

C$
Trademark Search in Canada
KALCEX & DESIGN

View On IC.GC.CA

KALCEX & DESIGN
REGISTERED

on 22 Sept 2022

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

KALCEKS AS

Krustpils iela 53Riga, LV-1057

LV

Serial Number

1841671 filed on 8th Jun 2017

Registration Number

TMA1143140 registered on 22nd Sept 2022

Registration expiry Date

22nd Sept 2032

Correspondent Address

AVENTUM IP LAW LLP

Suite 104, Tower A555 Legget DriveOttawa

ONTARIO

CA

K2K2X3

KALCEX & DESIGN

Trademark usage description

pharmaceutical active ingredients, their polymorphs, salts, solvates and hydrates for use in the manufacture of pharmaceutical salts that are used in Read More

Vienna Information

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 19

Letters overlappingLettres se chevauchant

26 . 5 . 1

One polygonUn polygone

26 . 5 . 19

Polygons with inscriptions projecting beyond the circumferencePolygones avec inscriptions débordant la circonférence

26 . 5 . 24

Polygons with dark surfaces or parts of surfacesPolygones avec surface ou partie de la surface foncée

29 . 1 . 4

BlueBleu

29 . 1 . 6

White, grey, silverBlanc, gris, argent

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

Classification Information

Class [001]
Pharmaceutical active ingredients, their polymorphs, salts, solvates and hydrates for use in the manufacture of pharmaceutical salts that are used in the manufacture of pharmaceuticals; hydrates, organic chemicals, inorganic chemicals and solvates for use in the manufacture of pharmaceuticals; Chemicals for use in the manufacture of pharmaceutical salts and pharmaceuticals.

Classification kind code

11

Class [005]
Pharmaceutical and veterinary preparations, namely, for use in the field of treatment of gastro-intestinal diseases, cardiovascular diseases, blood and blood forming diseases, nervous system diseases, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, cancer, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, hypnotics, sedatives, psychoanaleptics and psychostimulants, psychoanaleptics and psychostimulants for premedication intensive care, anti-viral agents, antineoplastic and immunomodulation diseases, musculoskeletal system diseases, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, non-steroid anti-inflammatory and antirheumatic products and muscle relaxants, dermatological diseases, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, antimicrobials for dermatologic use, sensory organ diseases, namely, ophthalmological diseases and disorders, ocular diseases and disorders, ear, nose and throat diseases and disorders, diseases and disorders effecting taste and smell, respiratory system diseases, genitourinary system diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases, infectious diseases, namely, respiratory infections, eye infections, prevention of inflammatory disorders, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, agents affecting metabolism and alimentary track, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, cancer, hormonal disorders, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, and thyroid hormone preparations, hypogonadism, testosterone/androgen disorders and estrogen disorders, allergies, for regulating the immune system and in the field of gynecology, urology, insecticides, repellents, namely, insect repellants, animal repellants, anti-parasitics, anesthesia, namely, regional, local and general anesthesia and narcosis, analgesics namely opioids and for postoperative pain, pain in patients with cancer and malignant tumours, diagnostic procedures, surgery pain and posts-urgery pain, moderate to severe pain, pain in the case of injuries, fractures of bones, burns, myocardial infarction, acute pancreatitis, renal, biliary and intestinal colic, non-steroid anti-inflammatories and antirheumatics and muscle relaxants, antibacterial pharmaceuticals, anti-infective pharmaceuticals, antiemetics and antinauseants for use during oncology and radiology therapy, vitamins for human and veterinary use

Classification kind code

11

Mark Details

Serial Number

1841671

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 67
on 4th Sept 2019		Agent Name Changed
Submitted for opposition 15
on 27th May 2019		Correspondence Created
Submitted for opposition 12
on 3rd Dec 2018		Extension of Time
Submitted for opposition 67
on 28th May 2018		Agent Name Changed
Submitted for opposition 68
on 28th May 2018		Rep for Service Name Changed
Submitted for opposition 22
on 23rd May 2018		Search Recorded
Submitted for opposition 20
on 23rd May 2018		Examiner's First Report
Submitted for opposition 31
on 14th Jun 2017		Formalized
Submitted for opposition 1
on 9th Jun 2017		Created
Submitted for opposition 30
on 8th Jun 2017		Filed